Patient
SITE005-0047
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE005 (FRA) (Dr. Muller)
consented 2025-10-25
Adverse events
3
Serious AEs
2
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-17 (study day 289); relationship: NOT RELATED
Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-07-05 (study day 62); relationship: NOT RELATED; serious criteria: hospitalization
Grade 3 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-06-06 (study day 33); relationship: NOT RELATED; serious criteria: hospitalization
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.